CB Therapeutics Enters into Collaboration Agreement with Cleveland Clinic for the Manufacture of Psilocybin, DMT and MDMA Therapeutic Compounds for Clinical Trials to Treat Depression, Addiction and PTSD

SAN DIEGO–(BUSINESS WIRE)– #clinicaltrials–CB Therapeutics enters agreement with Cleveland Clinic for biosynthesis of psilocybin, DMT, MDMA for depression, PTSD and addiction clinical trials.